Ilmarinen Mutual Pension Insurance Co Acquires 9,000 Shares of Danaher Corporation $DHR

Key Points

• Ilmarinen Mutual Pension Insurance Co increased its stake in Danaher Corporation by 10.5% during the 1st quarter, acquiring an additional 9,000 shares to reach a total of 94,500 shares valued at approximately $19.37 million.
• Danaher recently declared a quarterly dividend of $0.32 per share, reflecting an annualized payout of $1.28 and a dividend yield of 0.7%.
• Analysts are generally optimistic about Danaher's stock, with a consensus rating of "Moderate Buy" and an average price target of $246.35, suggesting potential for growth.

Ilmarinen Mutual Pension Insurance Co lifted its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 10.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,500 shares of the conglomerate's stock after purchasing an additional 9,000 shares during the period. Ilmarinen Mutual Pension Insurance Co's holdings in Danaher were worth $19,373,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Bank Pictet & Cie Europe AG grew its holdings in Danaher by 22.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after purchasing an additional 35,730 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Danaher by 7.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 63,534 shares of the conglomerate's stock worth $14,584,000 after purchasing an additional 4,388 shares during the period. Minot DeBlois Advisors LLC acquired a new stake in Danaher in the fourth quarter worth $1,606,000. Obermeyer Wealth Partners grew its holdings in Danaher by 25.6% in the fourth quarter. Obermeyer Wealth Partners now owns 2,012 shares of the conglomerate's stock worth $462,000 after purchasing an additional 410 shares during the period. Finally, OMERS ADMINISTRATION Corp grew its holdings in shares of Danaher by 74.3% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 50,202 shares of the conglomerate's stock valued at $11,524,000 after buying an additional 21,397 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.20% of the stock is owned by corporate insiders.

Danaher Stock Performance

Shares of DHR stock opened at $194.24 on Wednesday. The firm has a market cap of $139.09 billion, a price-to-earnings ratio of 41.33, a P/E/G ratio of 2.77 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The firm's 50-day simple moving average is $201.82 and its two-hundred day simple moving average is $199.20.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's dividend payout ratio is presently 27.23%.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. Royal Bank Of Canada set a $241.00 target price on Danaher in a report on Tuesday, September 2nd. Barclays reiterated an "overweight" rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Robert W. Baird upped their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Wells Fargo & Company cut their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 23rd. Finally, Guggenheim restated a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and an average price target of $246.35.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.